BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17152102)

  • 1. Structural and dynamic characterization of copper(II) binding of the human prion protein outside the octarepeat region.
    Berti F; Gaggelli E; Guerrini R; Janicka A; Kozlowski H; Legowska A; Miecznikowska H; Migliorini C; Pogni R; Remelli M; Rolka K; Valensin D; Valensin G
    Chemistry; 2007; 13(7):1991-2001. PubMed ID: 17152102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of copper(II) with the prion peptide fragment HuPrP(76-114) encompassing four histidyl residues within and outside the octarepeat domain.
    Di Natale G; Osz K; Nagy Z; Sanna D; Micera G; Pappalardo G; Sóvágó I; Rizzarell E
    Inorg Chem; 2009 May; 48(9):4239-50. PubMed ID: 19348438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper(II) interaction with prion peptide fragments encompassing histidine residues within and outside the octarepeat domain: speciation, stability constants and binding details.
    Osz K; Nagy Z; Pappalardo G; Di Natale G; Sanna D; Micera G; Rizzarelli E; Sóvágó I
    Chemistry; 2007; 13(25):7129-43. PubMed ID: 17566127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational studies of Cu(II)[peptide] binding motifs: Cu[HGGG] and Cu[HG] as models for Cu(II) binding to the prion protein octarepeat region.
    Pushie MJ; Rauk A
    J Biol Inorg Chem; 2003 Jan; 8(1-2):53-65. PubMed ID: 12459899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper(II) interaction with unstructured prion domain outside the octarepeat region: speciation, stability, and binding details of copper(II) complexes with PrP106-126 peptides.
    Di Natale G; Grasso G; Impellizzeri G; La Mendola D; Micera G; Mihala N; Nagy Z; Osz K; Pappalardo G; Rigó V; Rizzarelli E; Sanna D; Sóvágó I
    Inorg Chem; 2005 Oct; 44(20):7214-25. PubMed ID: 16180886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the human prion PrP(106-126) sequence with copper(II), manganese(II), and zinc(II): NMR and EPR studies.
    Gaggelli E; Bernardi F; Molteni E; Pogni R; Valensin D; Valensin G; Remelli M; Luczkowski M; Kozlowski H
    J Am Chem Soc; 2005 Jan; 127(3):996-1006. PubMed ID: 15656638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo design of a copper(II)-binding helix-turn-helix chimera: the prion octarepeat motif in a new context.
    Shields SB; Franklin SJ
    Biochemistry; 2004 Dec; 43(51):16086-91. PubMed ID: 15610003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new, model-free calculation method to determine the coordination modes and distribution of copper(II) among the metal binding sites of multihistidine peptides using circular dichroism spectroscopy.
    Osz K
    J Inorg Biochem; 2008 Dec; 102(12):2184-95. PubMed ID: 18973951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectroscopic and electronic structure studies of copper(II) binding to His111 in the human prion protein fragment 106-115: evaluating the role of protons and methionine residues.
    Rivillas-Acevedo L; Grande-Aztatzi R; Lomelí I; García JE; Barrios E; Teloxa S; Vela A; Quintanar L
    Inorg Chem; 2011 Mar; 50(5):1956-72. PubMed ID: 21261254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dimeric and tetrameric octarepeat fragments of prion protein behave differently to its monomeric unit.
    Valensin D; Luczkowski M; Mancini FM; Legowska A; Gaggelli E; Valensin G; Rolka K; Kozlowski H
    Dalton Trans; 2004 May; (9):1284-93. PubMed ID: 15252619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CuII binding sites located at His-96 and His-111 of the human prion protein: thermodynamic and spectroscopic studies on model peptides.
    Gralka E; Valensin D; Porciatti E; Gajda C; Gaggelli E; Valensin G; Kamysz W; Nadolny R; Guerrini R; Bacco D; Remelli M; Kozlowski H
    Dalton Trans; 2008 Oct; (38):5207-19. PubMed ID: 18813375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper binding to prion octarepeat peptides, a combined metal chelate affinity and immunochemical approaches.
    Todorova-Balvay D; Simon S; Créminon C; Grassi J; Srikrishnan T; Vijayalakshmi MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(1):75-82. PubMed ID: 15722047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insertion of beta-alanine in model peptides for copper binding to His96 and His111 of the human prion protein.
    Rivillas-Acevedo L; Maciel-Barón L; García JE; Juaristi E; Quintanar L
    J Inorg Biochem; 2013 Sep; 126():104-10. PubMed ID: 23796442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric determination of the coordination geometry of potential copper(II) surrogates for the mammalian prion protein octarepeat region.
    Pushie MJ; Ross AR; Vogel HJ
    Anal Chem; 2007 Aug; 79(15):5659-67. PubMed ID: 17608450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper binding to the prion protein: structural implications of four identical cooperative binding sites.
    Viles JH; Cohen FE; Prusiner SB; Goodin DB; Wright PE; Dyson HJ
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2042-7. PubMed ID: 10051591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence.
    Miura T; Hori-i A; Mototani H; Takeuchi H
    Biochemistry; 1999 Aug; 38(35):11560-9. PubMed ID: 10471308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential Cu2+ coordination by His96 and His111 induces beta-sheet formation in the unstructured amyloidogenic region of the prion protein.
    Jones CE; Abdelraheim SR; Brown DR; Viles JH
    J Biol Chem; 2004 Jul; 279(31):32018-27. PubMed ID: 15145944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-cleavage of the human prion protein impacts Cu(II) coordination at its non-octarepeat region.
    Sánchez-López C; Quintanar L
    J Inorg Biochem; 2022 Mar; 228():111686. PubMed ID: 34929540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The non-octarepeat copper binding site of the prion protein is a key regulator of prion conversion.
    Giachin G; Mai PT; Tran TH; Salzano G; Benetti F; Migliorati V; Arcovito A; Della Longa S; Mancini G; D'Angelo P; Legname G
    Sci Rep; 2015 Oct; 5():15253. PubMed ID: 26482532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics study of the Cu2+ binding-induced "structuring" of the N-terminal domain of human prion protein.
    Valensin G; Molteni E; Valensin D; Taraszkiewicz M; Kozlowski H
    J Phys Chem B; 2009 Mar; 113(11):3277-9. PubMed ID: 19236027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.